Unmasking the Diagnosis, Reclaiming the Child
Breaking the Spell of ADD/ADHD — Series Part II
“Amphetamines are a class of highly addictive drugs—yet we prescribe them to millions of children.”
— Dr. Peter Gøtzsche, Deadly Psychiatry and Organised Denial
In the quiet corners of school offices and the sterile rooms of pediatric clinics, a spell has been cast.
It whispers:
Your child is broken.
Your child is restless, not quite right.
The answer? A pill. A label. A lifelong identity.
The Diagnosis That Was Voted Into Being
ADD and ADHD were not discovered under a microscope. They were voted into being by committees—people, not microscopes, decided where to draw the line between “normal” and “disordered.”
Dr. Allen Frances, who once helped shape the DSM-IV, now warns that psychiatry has gone too far:
“We made mistakes that had terrible consequences. Diagnoses of ADD skyrocketed, and with them the use of stimulant drugs.”
— Saving Normal
In 1997, the FDA made a landmark decision: direct-to-consumer advertising of prescription drugs became legal. Soon, commercials promised that focus could be bought. Parents—facing overwhelmed classrooms and few alternatives—became customers.
A diagnosis once reserved for 3–5% of children now hovers at over 10%, and in some areas, approaches 20%.
And yet even these numbers hide the reach. Today, ADHD is casually self-diagnosed, mentioned in jokes, and treated like a personal brand. What began as a marginal disorder is now a social identity, a marketing demographic—and for many, a lifelong prescription.
The Cost of Compliance
“Prescription stimulants—like methylphenidate and amphetamines—have not been shown to change long-term academic outcomes, yet their use has surged.”
— Dr. Peter Gøtzsche
The landmark MTA study (2001), funded by the NIMH, found that any short-term improvements in behavior did not lead to better long-term academic or relational outcomes.
Meanwhile, the side effects are well-documented.
Dr. Peter Breggin writes:
“Ritalin and amphetamines have almost identical adverse effects on the brain, mind, and behavior, including psychosis, mania, drug abuse, and addiction.”
Yet parents are rarely warned of this. And the deeper question lingers:
Where is the definitive test for ADHD?
There is no blood marker. No brain scan. No x-ray.
Instead, diagnosis rests on checklists—subjectively interpreted—often under pressure from educators, doctors, or systems looking for quick fixes.
In truth, it has become far too easy to slap a diagnosis on a child to satisfy the expectations of a school, the hopes of a parent, or the demands of a system that no longer remembers how to listen.
What If the Problem Isn’t the Child?
“The question is not why the child is distracted.
The question is: what is the child reacting to?”
— Dr. Gabor Maté
Much of what we call ADHD arises not from defect—but from disconnection.
From trauma. From a system that prizes productivity over presence.
Waldorf education, trauma-informed classrooms, and nervous system regulation practices offer another way. They see restlessness not as illness—but as signal. A cry for rhythm, co-regulation, connection.
In this light, a child’s refusal to conform may be not a symptom—but a wisdom.
Breaking the Spell
We were sold a myth: that pills could fix what society refuses to face.
But the cost has been high:
Children numbed
Creativity dulled
The sacred wildness of the soul diagnosed out of existence
It is time to break the spell. To name the lie. To reclaim the child.
Let us restore the soul of education, the rhythm of care, and the sacredness of difference.
Part I: A Diagnosis in Question explores the creation of the ADHD label and the systems that benefited from its rise.
——————————————————————
References & Further Reading:
American Academy of Pediatrics. (2018). ADHD Clinical Practice Guidelines.
Breggin, Peter R. (1998). Talking Back to Ritalin: What Doctors Aren’t Telling You About Stimulants and ADHD. Perseus Publishing.
Frances, Allen. (2013). Saving Normal: An Insider's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. William Morrow.
Gøtzsche, Peter C. (2015). Deadly Psychiatry and Organised Denial. People's Press.
Jensen, Peter S., et al. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers. Pediatrics, 107(4), e68.
Lakhan, Shaheen E., & Kirchgessner, Annette. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain and Behavior, 2(5), 661–677.
Maté, Gabor. (2001). Scattered Minds: The Origins and Healing of Attention Deficit Disorder. Vintage Canada.
Whitaker, Robert, & Cosgrove, Lisa. (2015). Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform. Palgrave Macmillan.